A 32-year-old woman from Mumbai with a 5-year history of PCOD (confirmed by Rotterdam criteria: irregular cycles, hirsutism, elevated testosterone 1.2 ng/mL, polycystic ovaries on ultrasound) presents with secondary amenorrhea for the past 4 months. She has been on metformin 1500 mg daily for 2 years with good metabolic control (fasting glucose 92 mg/dL, BMI 23 kg/m²). Pelvic examination is unremarkable. Serum β-hCG is negative. TSH is 2.1 mIU/L. Pelvic ultrasound shows normal endometrial thickness (8 mm) and normal ovaries without dominant follicle. Serum progesterone on day 21 is 0.5 ng/mL. What is the most likely cause of her amenorrhea?

Explanation

## Clinical Analysis **Key Point:** This patient has PCOD with persistent anovulation despite adequate metformin therapy and metabolic control. The low day-21 progesterone (0.5 ng/mL, normal luteal phase >5 ng/mL) confirms anovulation. ## Differential Diagnosis of Secondary Amenorrhea in PCOD | Diagnosis | TSH | β-hCG | Progesterone | Endometrial Thickness | Ultrasound | |-----------|-----|-------|--------------|----------------------|------------| | **Persistent anovulation (PCOD)** | Normal | Negative | **<1 ng/mL** | Normal | No dominant follicle | | **Hypothyroidism** | **Elevated** | Negative | Low | May be thickened | Variable | | **Pregnancy** | Normal | **Positive** | Elevated | Thickened | Gestational sac | | **Asherman syndrome** | Normal | Negative | Low | **<5 mm** | Normal ovaries | | **Hyperprolactinemia** | Normal | Negative | Low | Normal | Normal ovaries, no follicle | **High-Yield:** The combination of normal TSH, negative β-hCG, normal endometrial thickness (8 mm), normal ovaries, and low day-21 progesterone in a patient with known PCOD on metformin points to **persistent anovulation** — metformin failure. ## Why Persistent Anovulation? ```mermaid flowchart TD A[PCOD patient on metformin]:::outcome --> B{Metabolic control achieved?}:::decision B -->|Yes| C[Reassess ovulation status]:::action C --> D{Progesterone >5 ng/mL on day 21?}:::decision D -->|Yes| E[Ovulation restored]:::outcome D -->|No| F[Persistent anovulation]:::urgent F --> G[Add clomiphene citrate]:::action G --> H{Ovulation achieved?}:::decision H -->|Yes| I[Continue clomiphene]:::action H -->|No| J[Consider letrozole or IVF]:::action B -->|No| K[Optimize metformin dose/lifestyle]:::action ``` **Clinical Pearl:** Metformin restores ovulation in only 30–40% of PCOD patients, even with good metabolic control. Persistent anovulation despite metformin requires escalation to clomiphene citrate or aromatase inhibitors. **Mnemonic: ANOVULATION DESPITE METFORMIN — A**dequate metabolic control, **N**ormal TSH/β-hCG, **O**varies polycystic, **V**ery low progesterone, **U**nresponsive to metformin, **L**ow day-21 progesterone, **A**dd clomiphene, **T**est again, **I**nsulin-resistant PCOD, **O**vulation failure, **N**eed escalation. ## Why Not the Other Options? **Hypothyroidism:** TSH is normal (2.1 mIU/L, normal range 0.4–4.0), ruling out primary hypothyroidism. Metformin does NOT cause hypothyroidism. **Asherman syndrome:** Endometrial thickness is normal (8 mm); Asherman syndrome presents with thin endometrium (<5 mm). No history of uterine instrumentation is mentioned. **Hyperprolactinemia:** While hyperprolactinemia can cause amenorrhea and mimic PCOD, this patient has confirmed PCOD with polycystic ovaries and elevated testosterone. Hyperprolactinemia would not explain the polycystic ovarian morphology.